12/20
02:03 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
12/18
08:51 am
aktx
Akari Therapeutics Announces Key Leadership Appointments
Medium
Report
Akari Therapeutics Announces Key Leadership Appointments
12/16
09:05 am
aktx
Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer
Low
Report
Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer
12/12
02:04 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
12/4
02:09 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Neutral
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/26
03:07 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/19
08:00 am
aktx
Akari Therapeutics Regains Full Nasdaq Compliance
High
Report
Akari Therapeutics Regains Full Nasdaq Compliance
11/18
03:07 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/14
04:15 pm
aktx
Akari Therapeutics Announces Successful Completion of Merger of Akari Therapeutics and Peak Bio
Medium
Report
Akari Therapeutics Announces Successful Completion of Merger of Akari Therapeutics and Peak Bio
11/10
02:03 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/8
08:00 am
aktx
Akari Therapeutics Announces Shareholder Approval in Connection With Peak Bio, Inc. Merger
Low
Report
Akari Therapeutics Announces Shareholder Approval in Connection With Peak Bio, Inc. Merger
11/2
02:10 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/25
02:08 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/17
02:02 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/15
08:00 am
aktx
Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger
Medium
Report
Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger
10/9
02:02 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/1
02:08 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
9/23
02:07 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.